Even if Ttl levels assessed at mRNA level from whole tumor tissues acceptably substantiates the prognostic value of TTL expression in human tumor tissues, our study suggests that it is much more accurate to address it at protein level in stromal compartment e.g. by immunohistochemistry for TTL or detyrosinated tubulin. Here, TTL is linked to neoplasm.